An update on novel oral anticoagulants

Research output: Contribution to journalArticle

Abstract

Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalJapanese Journal of Neurosurgery
Volume24
Issue number4
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Anticoagulants
Stroke
Atrial Fibrillation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

An update on novel oral anticoagulants. / Ago, Tetsuro; Wakisaka, Yoshinobu; Kuroda, Junya.

In: Japanese Journal of Neurosurgery, Vol. 24, No. 4, 01.01.2015, p. 220-225.

Research output: Contribution to journalArticle

@article{d8c06c0633fa4ef19cdbc1fe0c27ca00,
title = "An update on novel oral anticoagulants",
abstract = "Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.",
author = "Tetsuro Ago and Yoshinobu Wakisaka and Junya Kuroda",
year = "2015",
month = "1",
day = "1",
doi = "10.7887/jcns.24.220",
language = "English",
volume = "24",
pages = "220--225",
journal = "Japanese Journal of Neurosurgery",
issn = "0917-950X",
publisher = "Japanese Congress of Neurological Surgeons",
number = "4",

}

TY - JOUR

T1 - An update on novel oral anticoagulants

AU - Ago, Tetsuro

AU - Wakisaka, Yoshinobu

AU - Kuroda, Junya

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.

AB - Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.

UR - http://www.scopus.com/inward/record.url?scp=84928593942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928593942&partnerID=8YFLogxK

U2 - 10.7887/jcns.24.220

DO - 10.7887/jcns.24.220

M3 - Article

AN - SCOPUS:84928593942

VL - 24

SP - 220

EP - 225

JO - Japanese Journal of Neurosurgery

JF - Japanese Journal of Neurosurgery

SN - 0917-950X

IS - 4

ER -